CD274 and neoplasm: While different trials have demonstrated important changes in the tumor microenvironment as a result of neoadjuvant treatments, little is known about the impact of treatment modalities such as CT, radiotherapy (RT), and chemoradiation therapy (CRT) on PD-L1 expression, especially in the absence of an ICI.